What is it?
Beta-carotene is a substance from plants that the body converts into vitamin A. It also acts as an antioxidant and an immune system booster.
Other members of the antioxidant carotenoid family include cryptoxanthin, alpha-carotene,
zeaxanthin, lutein, and lycopene. However, unlike beta-carotene, most of these
nutrients are not converted to vitamin A in significant amounts.
Where is it found?
Dark green and orange-yellow vegetables are good sources of beta-carotene. It is also
available in supplements.
Beta-carotene has been
used in connection with the following conditions (refer to the
individual health concern for complete information):
Who is likely to be deficient?
People who limit their consumption of beta-carotene-containing vegetables could be at
higher risk of developing a vitamin A
deficiency. However, because beta-carotene is not an essential nutrient, true deficiencies do
not occur. Nevertheless, very old persons with type 2 diabetes have shown a significant age-related decline
in blood levels of carotenoids, irrespective of their dietary intake.1
How much is usually taken?
The most common beta-carotene supplement intake is probably 25,000 IU (15 mg) per day,
though some people take as much as 100,000 IU (60 mg) per day. Whether the average person
would benefit from supplementation with beta-carotene remains unclear.
Are there any side effects or interactions?
Beta-carotene supplementation, even in very large amounts, is not known to cause any
serious side effects,16 17 however, excessive intake (more than 100,000
IU, or 60 mg per day) sometimes gives the skin a yellow-orange hue. People taking
beta-carotene for long periods of time should also supplement with vitamin E, as beta-carotene may reduce vitamin E
levels.18 Beta carotene supplementation may also decrease blood levels of lutein, another carotenoid.19
Warning: Synthetic beta-carotene has now been linked to increased
risk of lung cancer in smokers. Until more is
known, smokers should avoid all beta-carotene supplements.
Preliminary studies in animals indicate that beta-carotene supplementation, when combined
with heavy alcohol consumption, may enhance
liver toxicity.20 Until more is known, alcoholics and persons who consume alcohol
on a daily basis should avoid supplementing with beta-carotene.
One study showed a slightly increased risk of vascular surgery among people with intermittent claudication who took beta-carotene
supplements.21 Until more is known, persons wishing to use beta-carotene
supplements should first consult with their doctor.
Are there any drug
interactions?
Certain medicines may interact with beta-carotene. Refer to drug interactions for a list of those medicines.
References
(To view, roll mouse over heading; to hide, click on heading)
1. Polidori MC, Mecocci P, Stahl W, et al. Plasma levels of lipophilic
antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev
2000;16:15–9.
2. Shekelle RB, Lepper M, Liu S, et al. Dietary vitamin A and risk of
cancer in the Western Electric Study. Lancet 1981;2:1185–90.
3. Hennekens CH, Burning JE, Manson JE, et al. Lack of effect of
long-term supplementation with beta carotene on the incidence of malignant neoplasms and
cardiovascular disease. N Engl J Med 1996;334:1145–9.
4. Albanes D, Heinone OP, Taylor PR, et al. Alpha-tocopherol and
beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene
Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl
Cancer Inst 1996;88:1560–70.
5. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination
of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J
Med 1996;334:1150–5.
6. Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and
incidence of cancer and cardiovascular disease: the Women’s Health Study. J Natl
Cancer Inst 1999;91:2102–6.
7. Törnwall ME, Virtamo J, Haukka JK, et al. The effect of
alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent
claudication in a controlled trial. Atherosclerosis 1999;147:193–7.
8. Wang XD, Liu C, Bronson RT, et al. Retinoid signaling and activator
protein-1 expression in ferrets given ß-carotene supplements and exposed to tobacco
smoke. J Natl Cancer Inst 1999;91:60–6.
9. You CS, Parker RS, Goodman KJ, et al. Evidence of cis-trans
isomerization of 9-cis-beta-carotene during absorption in humans. Am J Clin Nutr
1996;64:177–83.
10. Tamai H, Morinobu T, Murata T, et al. 9-cis beta-carotene in human
plasma and blood cells after ingestion of beta-carotene. Lipids
1995;30:493–8.
11. Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture
compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr
1996;63:729–34.
12. Bitterman N, Melamed Y, Ben-Amotz A. Beta-carotene and CNS oxygen
toxicity in rats. J Appl Physiol 1994;76:1073–6.
13. Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture
compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr
1996;63:729–34.
14. Yeum KJ, Azhu S, Xiao S, et al. Beta-carotene intervention trial in
premalignant gastric lesions. J Am Coll Nutr 1995;14:536 [abstr #48].
15. Neuman I, Nahum H, Ben-Amotz A. Prevention of exercise-induced asthma
by a natural isomer mixture of beta-carotene. Ann Allergy Asthma Immunol
1999;82:549–53.
16. Olson JA. Recommended dietary intakes (RDI) of vitamin A in humans.
Am J Clin Nutr 1987;45:704–16.
17. Heywood R, Palmer AK, Gregson RL, Hummler H. The toxicity of
beta-carotene. Toxicology 1985;36:91–100.
18. Xu MJ, Plezia PM, Alberts DS, et al. Reduction in plasma or skin
alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans
and mice. J Natl Cancer Inst 1992;84:1559–65.
19. Gossage C, Deyhim M, Moser-Veillon PB, et al. Effect of beta-carotene
supplementation and lactation on carotenoid metabolism and mitogenic T lymphocyte
proliferation. Am J Clin Nutr 2000;71:950–5.
20. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse
interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr
1999;69:1071–85 [review].
21. Törnwall ME, Virtamo J, Haukka JK, et al. The effect of
alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent
claudication in a controlled trial. Atherosclerosis 1999;147:193–7.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the
company.
Learn more about the authors of
Healthnotes.
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.